Prostanglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway by Zeddou, Mustapha et al.
Prostanglandin E2 induces the expression of functional inhibitory 
CD94/NKG2A receptors in human CD8+ T lymphocytes by a 
cAMP-dependent protein kinase A type I pathway 
 
Mustapha Zeddou, Michel Moutschen and Souad Rahmouni  
Department of Pathology, University of Liège, Belgium 
 
Abstract 
The CD94/NKG2A heterodimer is a natural killer receptor (NKR), which inhibits cell-
mediated cytotoxicity upon interaction with MHC class I gene products. It is expressed by NK 
cells and by a small fraction of activated T cells, predominantly of CD8+ phenotype. 
Abnormal upregulation of the CD94/NKG2A inhibitory NKR on cytotoxic T cells (CTLs) 
could be responsible for a failure of immunosurveillance in cancer or HIV infection. In an 
attempt to identify the mechanisms leading to inhibitory NKR upregulation on T cells, we 
analyzed the expression of the CD94/NKG2A heterodimer on human CTLs activated with 
anti-CD3 mAb in the presence of PGE2 or with 8-CPT-cAMP, an analogue of cyclic AMP. As 
previously described, anti-CD3 mAb-mediated activation induced the expression of 
CD94/NKG2A on a small fraction of CD8+ T cells. Interestingly, when low concentrations of 
PGE2 or 8-CPT-cAMP were present during the culture, the proportion of CD8+ T cells 
expressing CD94/NKG2A was 2 to 5-fold higher. This upregulation was partially prevented 
by the PKA type I inhibitor, Rp-8-Br-cAMP. We also report that cAMP induces upregulation 
of NKG2A at the mRNA level. We further demonstrated that cross-linking of CD94 on CD8+ 
T cells expressing the CD94/NKG2A heterodimer inhibits their cytotoxic activity in a 
bispecific antibody redirected lysis assay. Our findings clearly demonstrate that the 
PGE2/cAMP/PKA type I axis is involved in the expression of CD94/NKG2A receptor on 
human CD8+ T lymphocytes. 
 
